Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Prospective Post-Market Clinical Follow-Up Study of the G7® Freedom Constrained Vivacit-E® Liners

NCT05587244 is registered in ClinicalTrials.gov with Zimmer Biomet as lead sponsor.

NCT NCT05587244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05587244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Prospective Post-Market Clinical Follow-Up Study of the G7® Freedom Constrained Vivacit-E® Liners
Lead sponsor
Zimmer Biomet
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
May 8, 2023
Completion date
December 31, 2038
Enrollment
202 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

avascular necrosis, dislocation, hip, femoral neck fractures, non-union fracture, osteoarthritis, hip, rheumatoid arthritis, trochanteric fractures